logo

Regeneron Pharmaceuticals (REGN)



Trade REGN now with
  Date
  Headline
11/23/2021 1:16:30 AM Nykode Enters Into Agreement With Regeneron To Develop Innovative Vaccines Against Cancer And Infectious Diseases
11/12/2021 4:26:52 PM Regeneron Announces $3 Bln Share Repurchase Program
11/8/2021 7:02:43 AM Regeneron : Phase 3 Analyses Show Single Dose Of REGEN-COV Provides Long-term Protection Against COVID-19
11/4/2021 10:02:55 AM Regeneron To Present Clinical Research Data On Blood Cancers And Disorders
11/4/2021 6:32:03 AM Regeneron Q3 Revenues Increase 51% To $3.45 Bln
10/25/2021 1:03:42 AM Regeneron, Sanofi Announce Second Phase 3 Trial Of Dupixent Meets Co-primary Endpoints In Eosinophilic Esophagitis
10/22/2021 1:01:34 AM Regeneron : Dupixent Significantly Reduced Itch At 12 Weeks
10/14/2021 7:26:25 AM Regeneron: FDA Accepts For Priority Review BLA For REGEN-COV To Treat Prophylaxis Of COVID-19